Navigation Links
Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
Date:9/10/2008

Feldmann and Maini Honored for Discovery of New Class of Anti-Inflammatory

Drugs

BEERSE, Belgium, Sept. 10 /PRNewswire/ -- The 2008 recipients of The Dr. Paul Janssen Award for Biomedical Research, Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London, are being honored during a scientific symposium today and at a formal award ceremony at the Dr. Paul Janssen Research Center in Beerse, Belgium tomorrow. Feldmann and Maini received the $100,000 prize for their role in the discovery of tumor necrosis factor-alpha (TNF-alpha) as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions.

"Thanks to their pioneering biomedical research, Feldmann and Maini have significantly improved the lives of millions of patients with chronic inflammatory conditions," said Paul Stoffels, company group chairman, Global Research and Development, Pharmaceuticals, Johnson & Johnson. "We are delighted that the 2008 Dr. Paul Janssen Award is going to two researchers with a lifelong commitment to translational research. Their achievements would have been greatly appreciated by Dr. Paul Janssen, who himself was instrumental in the development of many important medicines."

For more than 20 years, Feldmann and Maini have collaborated on basic research and clinical trials that have transformed the treatment of people diagnosed with chronic inflammatory conditions. Feldmann and Maini investigated the role of cytokines, protein messenger molecules that drive inflammation, and found that a single cytokine, TNF-alpha, was responsible for the debilitating symptoms of inflammatory disease. In seeking ways to block TNF-alpha, they studied a monoclonal antibody previously developed for an unrelated condition. Clinical trials revealed rapid and dramatic improvement of rheumatoid disease a
'/>"/>

SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
2. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
5. Johnson & Johnson Announces Changes to Accelerate Growth
6. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
7. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
8. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
9. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
10. Craig Johnson Joins Ardea Biosciences Board of Directors
11. Migenix averts proxy contest; reaches agreement with DJohnson holdings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...d, November 24 deCODE,ge...it has received notice from,the Nasdaq Stock Marke...be,suspended as of November 30, 2009 and a Form 25...e Commission, which will remove deCODE,s common st...es an appeal to the Nasdaq,Listing Qualifications ...
(Date:11/24/2009)...Newswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: N...loping and commercializing novel pain management t...esident and Chief Executive Officer, is scheduled ... Care Conference, to be held December 1-2, 2009 at... ,, Mr. DiTonno and Stephen Ghiglieri, Chief Fi...
(Date:11/24/2009)...Nov. 24 /PRNewswire-FirstCall/ - Hamilton Thorne L... leading provider of advanced laser systems and in... clinic markets, today reported operational and fi...ber 30, 2009. , , Q3 2009 Highlights, - ...ion in Q3 2008, - Gross profit margin was 66....
(Date:11/24/2009)...tomers with Partners Validated to Process and Anal... Ottawa, ON (PRWEB) Novemb...f products for biological sample collection, stabi...global partner program. The program offers signifi...ity and is designed to help partners scale and dif...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ussing how to rewrite the entire statute that gove...unications, said Kathleen Abernathy, an FCC Commis...ernathy spoke to communications executives gathere...ns & Technology Conference in Milwaukee. , ,"In a ...ple competitors offer a variety of entrepreneurial...
...endment is attached to an otherwise welcome bill i...the bill is cleansed of bad ideas as it bounces be...owever, a real clunker slips through. , ,That,s wh... bill to grant research and development tax credit... those credits to firms focusing on human cloning ...
...aukee-based Fiserv Inc. and InsightAmerica are w...ustomers, identities before a financial institutio...lions of public records to authenticate a customer...InsightAmerica, a supplier of risk mitigation tool...s from identity theft. , ,In addition to checking ...
Other Biology Technology:FCC may restructure to tackle broadband regulation 2Attempt to exclude stem cell companies from tax credit bill hurts Wisconsin 2Attempt to exclude stem cell companies from tax credit bill hurts Wisconsin 3
(Date:11/23/2009).... The community-associated strain of the deadly s...t to most common antibioticsposes a far greater he...s way into hospitals, according to a study in the ... , The new threat is easily picked up in fitness... increased the overall burden of MRSA within hospi...
(Date:11/23/2009)...y the Wildlife Conservation Society says that west...e Republic of Congopart of the "mother lode" of mo...ecoming increasingly threatened by growing humans ...rotection of the swamp forests adjacent to the sou...cent surveys confirmed that high densities of the ...
(Date:11/23/2009)...l. A new study provides "incontrovertible evidenc... island of Sumatra about 73,000 years ago deforest...e epicenter, researchers report. , The volcano e...to the atmosphere, leaving a crater (now the world...ong and 35 kilometers wide. Ash from the event has...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2National Alliance of Wound Care Has Credentialed Over 7000 Wound Care Professionals 49356 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 2Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 4Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Associations 2009 Annual Meeting 49350 1Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Associations 2009 Annual Meeting 49350 2
...ey say is a relatively simple method, scientists a...ted stem/progenitor cells from testes and have con...tem cells. Researchers say that the nave cells are... type that a body needs, from brain neurons to pan... stem cells without the use of additional genes, t...
...ral common genetic variants related to a risk fact...early online release in the journal Nature Geneti...ome newly discovered, that influence the QT interv...ed routinely in doctors, offices. These findings c...th and arrhythmia by limiting the use of medicatio...
...e neuronal disease Troyer syndrome, was thought to...sue of the Journal of Cell Biology ( www.jcb.org... Spartin in regulating the cell,s lipid storage de...oplets (LDs), where they are kept until needed as ...rmation and regulation. Spartin hadn,t been connec...
Other Biology News:Human adult testes cells can become embryonic-like 2Common gene variants influence risk factor for sudden cardiac death 2Common gene variants influence risk factor for sudden cardiac death 3
... color staining method for labeling DNA breaks and...low cytometry. The kit contains the instructions a...lls including: positive and negative control cells...ion and rinsing buffers for processing individual ...
PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
Stirbar, Trans-Blot Plus cell from Bio-Rad
Criterion Staining and Blotting Trays, with lids, 12 from Bio-Rad
Biology Products: